(Q40549969)

21 September 2017

The CTA1-DD vaccine adjuvant binds to human B cells and potentiates their T cell stimulating ability (English)

1 reference

21 September 2017

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00567-X

1 April 2024

author name string

A. Eriksson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615145

1 April 2024

N. Lycke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615145

1 April 2024

language of work or name

English

0 references

publication date

1 December 2003

1 reference

21 September 2017

12 December 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14615145

full work available at URL

1 April 2024

https://api.elsevier.com/content/article/PII:S0264410X0300567X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00567-X

https://api.elsevier.com/content/article/PII:S0264410X0300567X?httpAccept=text/plain

1 April 2024

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00567-X

1 April 2024

1 reference

21 September 2017

22

1 reference

21 September 2017

2

1 reference

21 September 2017

185-193

1 reference

Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines.

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Immunoglobulin E and G responses to pertussis toxin after booster immunization in relation to atopy, local reactions and aluminium content of the vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Adjuvants--a classification and review of their modes of action

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Modulation of immune responses following antigen administration by mucosal route

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Immunomodulation using bacterial enterotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Optimism over vaccines administered via mucosal surfaces.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

1 reference

7 January 2021

AB5 ADP-ribosylating toxins: comparative anatomy and physiology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

The interaction between different domains of staphylococcal protein A and human polyclonal IgG, IgA, IgM and F(ab')2: separation of affinity from specificity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

The ADP-Ribosylating CTA1-DD Adjuvant Enhances T Cell-Dependent and Independent Responses by Direct Action on B Cells Involving Anti-Apoptotic Bcl-2- and Germinal Center-Promoting Effects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

The mechanism of cholera toxin adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

A synthetic IgG-binding domain based on staphylococcal protein A.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Constitutive production of interleukin-8 (IL-8) by normal and malignant human B-cells and other cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

A critical role for B cells in the development of memory CD4 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Role of B cells as antigen-presenting cells in vivo revisited: antigen-specific B cells are essential for T cell expansion in lymph nodes and for systemic T cell responses to low antigen concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Resting B lymphocytes as APC for naive T lymphocytes: dependence on CD40 ligand/CD40

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Role of interleukin 6 for differential responsiveness of naive and memory CD4+ T cells in CD2-mediated activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in B-lymphocyte function.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Tumor necrosis factor-alpha facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Interleukin-8-induced human peripheral blood B-lymphocyte chemotaxis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

The B cell targeted adjuvant, CTA1-DD, exhibits potent mucosal immunoenhancing activity despite pre-existing anti-toxin immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Enhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900567-X

7 January 2021

Aluminum compounds as vaccine adjuvants

4

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00567-X

Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications.

1 April 2024

20

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00567-X

The B-cell targeted CTA1-DD vaccine adjuvant is highly effective at enhancing antibody as well as CTL responses

1 April 2024

24

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00567-X

1 April 2024

Helivax Antex Biologics

48

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00567-X

1 April 2024

Identifiers

1 reference

release_x62mh3fwp5bhpavocser6nqif4

21 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/x62mh3fwp5bhpavocser6nqif4

24 November 2022

mapped directly with Wikidata item

1 reference